Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma

This case series describes the kinetics of humoral deficiency in patients with relapsed refractory multiple myeloma treated with bispecific antibodies, the infectious complications, and response to COVID-19 immunization.

Detalles Bibliográficos
Autores principales: Hammons, Lindsay R., Szabo, Aniko, Janardan, Abhishek, Dhakal, Binod, Chhabra, Saurabh, D’Souza, Anita, Mohan, Meera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617177/
https://www.ncbi.nlm.nih.gov/pubmed/36306135
http://dx.doi.org/10.1001/jamanetworkopen.2022.38961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617177/
https://www.ncbi.nlm.nih.gov/pubmed/36306135
http://dx.doi.org/10.1001/jamanetworkopen.2022.38961

Ejemplares similares